Phase II Trial of Perifosine in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 01 May 2014
At a glance
- Drugs Perifosine (Primary)
- Indications Chronic lymphocytic leukaemia; Lymphoid leukaemia
- Focus Therapeutic Use
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2012 Planned End Date changed from 1 Aug 2014 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 17 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.